Cardiac sympathetic dysfunction in genotyped patients with arrhythmogenic right ventricular cardiomyopathy and risk of recurrent ventricular tachyarrhythmias

Journal of Nuclear Medicine

Volumn 52, Issue 10, 2011, Pages 1559-1565

  Paul, Matthias ^a   Wichter, Thomas ^a   Kies, Peter ^a   Gerss, Joachim ^b   Wollmann, Christian ^a   Rahbar, Kambiz ^a   Eckardt, Lars ^a   Breithardt, Gun̈ter ^a   Schober, Otmar ^a   Schulze Bahr, Eric ^a   Schaf̈ers, Michael ^a,b  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

123I MIBG; Arrhythmogenic right ventricular cardiomyopathy; Risk stratification; Scintigraphy; Sympathetic nervous system

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; ELECTROCARDIOGRAPHY; FEMALE; GENE; GENE MUTATION; GENOTYPE; HEART DEPOLARIZATION; HEART REPOLARIZATION; HEART RIGHT VENTRICLE DYSPLASIA; HEART RIGHT VENTRICLE FAILURE; HEART VENTRICLE TACHYCARDIA; HEART VENTRICLE WALL MOTION; HUMAN; MALE; NEUROLOGIC DISEASE; PKP 2 GENE; PRIORITY JOURNAL; RADIOACTIVITY; RECURRENT DISEASE; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPATHETIC INNERVATION;

3-IODOBENZYLGUANIDINE; ADULT; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HEART; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; MUTATION; PLAKOPHILINS; RADIOPHARMACEUTICALS; RECURRENCE; RISK FACTORS; SYMPATHETIC NERVOUS SYSTEM; TACHYCARDIA, VENTRICULAR; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 80053494376     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.111.088997     Document Type: Article

References (14)

1. Jacobson AF, Senior R, Cerqueira MD, et al. ADMIRE-HF Investigators. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure: results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol. 2010;55:2212-2221.
2. Wichter T, Hindricks G, Lerch H, et al. Regional myocardial sympathetic dysinnervation in arrhythmogenic right ventricular cardiomyopathy: an analysis using 123I-meta-iodobenzylguanidine scintigraphy. Circulation. 1994;89:667-683.
3. Marcus FI, Fontaine GH, Guiraudon G, et al. Right ventricular dysplasia: a report of 24 cases. Circulation. 1982;65:384-398. (Pubitemid 12219036)
4. Gerull B, Heuser A, Wichter T, et al. Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat Genet. 2004;36:1162-1164. (Pubitemid 41288964)
5. Sen-Chowdhry S, Morgan RD, Chambers JC, McKenna WJ. Arrhythmogenic cardiomyopathy: etiology, diagnosis, and treatment. Annu Rev Med. 2010;61:233-253.
6. Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation. 2010;121:1533-1541.
7. Wichter T, Matheja P, Eckardt L, et al. Cardiac autonomic dysfunction in Brugada syndrome. Circulation. 2002;105:702-706. (Pubitemid 34157373)
8. Schäfers M, Wichter T, Lerch H, et al. Cardiac 123I-MIBG uptake in idiopathic ventricular tachycardia and fibrillation. J Nucl Med. 1999;40:1-5. (Pubitemid 29044163)
9. Wichter T, Schäfers M, Rhodes CG, et al. Abnormalities of cardiac sympathetic innervation in arrhythmogenic right ventricular cardiomyopathy. Quantitative assessment of presynaptic norepinephrine reuptake and postsynaptic β-adrenergic receptor density with positron emission tomography. Circulation. 2000;101: 1552-1558. (Pubitemid 30180892)
10. Morozumi T, Kusuoka H, Fukuchi K, et al. Myocardial iodine-123- metaiodobenzylguanidine images and autonomic nerve activity in normal subjects. J Nucl Med. 1997;38:49-52. (Pubitemid 27026996)
11. 123I-metaiodobenzylguanidine in patients with various heart diseases. Ann Nucl Med. 2007;21:513-520.
12. Agostini D, Verberne HJ, Burchert W, et al. I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study. Eur J Nucl Med Mol Imaging. 2008;35:535-546.
13. Göhl K, Feistel H, Weikl A, Bachmann K, Wolf F. Congenital myocardial sympathetic dysinnervation (CMSD) - a structural defect of idiopathic long QT syndrome. Pacing Clin Electrophysiol. 1991;14:1544-1553.
14. O'Donoghue M, Braunwald E. Natriuretic peptides in heart failure: should therapy be guided by BNP levels? Nat Rev Cardiol. 2010;7:13-20.